Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 908-552-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- Study was started on 17 December 2009 and was completed on 23 February 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Disodium sulphide
- EC Number:
- 215-211-5
- EC Name:
- Disodium sulphide
- Cas Number:
- 1313-82-2
- Molecular formula:
- Na2S
- IUPAC Name:
- disodium sulfide
- Reference substance name:
- sodium sulfide, anhydrous
- IUPAC Name:
- sodium sulfide, anhydrous
- Details on test material:
- - Name of test material (as cited in study report): Sodium sulfide, anhydrous
- Molecular formula (if other than submission substance): 78.04 g/mol
- Substance type: technical product
- Physical state: solid, slightly yellow granules
- Storage condition of test material: stored at 2 to 8°C in the dark, with desiccant and under nitrogen
Constituent 1
Constituent 2
Method
- Target gene:
- hprt locus
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- The master stock of L5178Y tk +/- mouse lymphoma cells originated from Dr Donald Clive, Burroughs Wellcome Co.
- Type and identity of media: RPMI 1640 media supplemented with heat inactivated horse serum (0%, 10% and 20%, respectively), 100 units/mL penicillin, 100 µg/mL streptomycin, 2.5 µg/mL Amphotericin B and 0.5 mg/mL pluronic (except for RPMI 20%) were used.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes; Each batch of cells was checked for that it was mycoplasma free.
- Periodically "cleansed" against high spontaneous background: yes; Each batch of cells was purged of TK- mutants, checked for spontaneous mutant frequency.
The cells diluted in RPMI 10 and incubated in a humidified atmosphere of 5% v/v CO2 in air. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- Concentrations selected for the Mutation Experiments were based on the results of this cytotoxicity Range-Finder Experiment. Values are based on test material (Na2S, anhydrous).
Range-Finder:
- with metabolic activation: 24.41, 48.81, 97.63, 195.3, 390.5 and 781.0 µg/mL
- without metabolic activation: 24.41, 48.81, 97.63, 195.3, 390.5 and 781.0 µg/mL
Experiment I:
- with metabolic activation: 50, 100, 150, 200, 300, 400*, 500*, 600*, 700* and 781 µg/mL
- without metabolic activation: 50, 100*, 150*, 200, 300*, 400*, 500*, 600*, 700 and 781 µg/mL
Experiment II:
- with metabolic activation: 100, 200, 400*, 600*, 650*, 700*, 720*, 740*, 760* and 781 µg/mL
- without metabolic activation: 50*, 100*, 200*, 400*, 500*, 600*, 625*, 650*, 700 and 781 µg/mL
* = Concentrations selected for mutation assessment. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: purified water
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Treatments with the vehicle purified water diluted 10 fold in the treatment medium.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- without metabolic activation
Migrated to IUCLID6: 0.1 and 0.15 µg/mL; dissolved in DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Treatments with the vehicle purified water diluted 10 fold in the treatment medium.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- with metabolic activation
Migrated to IUCLID6: 2.0 and 3.0 µg/mL; dissolved in DMSO
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 3 hours at 37 +/- 1°C
After incubation, the cells washed and resuspended in RPMI 10 medium. Cells were transferred to flasks for growth through the expression period or were diluted to be plated for survival (scoring after 7 days).
- Expression time (cells in growth medium): Cultures were maintained for a period of 7 days during which the hprt- mutation would be expressed.
Thereafter cultures were selected to be plated for viability and 6TG resistance.
- Selection time (if incubation with a selection agent): 12 to 13 days; At the end of the expression period, the cell suspension was placed into each well of 4 x 96 well microtitre plates (384 wells at 2 x 10^4 cells/well). Plates were incubated at 37 +/-1ºC in a humidified incubator gassed with 5% v/v CO2 in air until scoreable and wells containing clones were identified and counted.
SELECTION AGENT (mutation assays): 6-thioguanine (6TG)
NUMBER OF REPLICATIONS: Each treatment, in the absence or presence of S9 mix, was performed in duplicate cultures (single cultures only used for positive control treatments).
EVALUATION: Wells containing viable clones were identified by eye using background illumination and counted.
DETERMINATION OF CYTOTOXICITY
- Method: relative survival:
Single cultures only were used and positive controls were not included. Following treatment, cells were washed with tissue culture medium and resuspended in tissue culture medium. Cells were plated into each well of a 96 well microtitre plate for determination of relative survival. The plates were incubated at 37 +/- 1ºC in a humidified incubator gassed with 5% v/v CO2 in air for 7 days. Wells containing viable clones were identified by eye using background illumination and counted.
OTHER: Plating efficiency (PE), percentage relative survival (% RS) and mutant frequency (MF) were determined. - Evaluation criteria:
- For valid data, the test article was considered to induce forward mutation at the hprt locus in mouse lymphoma L5178Y cells if:
1. the mutant frequency at one or more concentrations was significantly greater than that of the negative control (p<0.05),
2. there was a significant concentration relationship as indicated by the linear trend analysis (p<0.05),
3. the effects described above were reproducible.
Results that only partially satisfied the assessment criteria described above were considered on a case-by-case basis. - Statistics:
- Statistical significance of mutant frequencies was carried out according to the UKEMS guidelines. Thus the control log mutant frequency (LMF) was compared with the LMF from each treatment concentration, and secondly the data were checked for a linear trend in mutant frequency with test article treatment. These tests require the calculation of the heterogeneity factor to obtain a modified estimate of variance.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- In both experiments there were no significant increases in MF at any concentration analysed.
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- A weak but statistically significant linear trend was observed in the presence of S9 mix in Experiment II but, in the absence of any marked increases in mutant frequency at any test article concentration analysed in this experiment, this observation was not considered biologically relevant.
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH and osmolality: At the highest concentration tested in the cytotoxicity Range-Finder Experiment (781 µg/mL), no marked changes in osmolality, compared to the concurrent vehicle controls, were observed but a marked increase in pH (of ≥1 unit, compared to the concurrent vehicle controls) was observed at 781 µg/mL in the absence and presence of S9 mix. Further pH measurements were therefore taken in Experiments I and II.
In Experiment I, marked increases in pH (of ≥1 unit, compared to the concurrent vehicle controls) were observed at 500 µg/mL in the absence and presence of S9 mix. In Experiment II, marked increases in pH (of ≥1 unit, compared to the concurrent vehicle controls) were observed at 400 µg/mL and above in the absence of S9 mix and at 600 µg/mL and above in the presence of S9 mix.
However, the marked increases in pH observed in the absence and presence of S-9 did not affect the interpretation of the data, as there were no significant increases in mutant frequency.
- Water solubility: Preliminary solubility data indicated that Sodium sulfide, anhydrous was soluble in water for irrigation (purified water) at a concentration of to at least 12.88 mg/mL. The solubility limit in culture medium was in excess of 1288 µg/mL (no precipitation was present at this concentration 3 hours after test article addition).
RANGE-FINDING/SCREENING STUDIES: In the cytotoxicity Range-Finder Experiment, 6 concentrations were tested in the absence and presence of S9 mix ranging from 24.41 to 781 µg/mL (equivalent to 10 mM at the highest concentration tested). The highest concentration to provide >10% RS was 390.5 µg/mL, which gave 68% and 53% RS in the absence and presence of S9 mix, respectively.
COMPARISON WITH HISTORICAL CONTROL DATA: no
ADDITIONAL INFORMATION ON CYTOTOXICITY: no further data - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative It is concluded that Sodium sulfide, anhydrous did not induce mutation at the hprt locus of L5178Y mouse lymphoma cells when tested under the conditions employed in this study.
It is concluded that Sodium sulfide, anhydrous did not induce mutation at the hprt locus of L5178Y mouse lymphoma cells when tested under the conditions employed in this study. These conditions included treatments up to toxic concentrations in two independent experiments in the absence and presence of a rat liver metabolic activation system (S9 mix). - Executive summary:
Sodium sulfide, anhydrous was assayed for mutation at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus (6 -thioguanine [6TG] resistance) in mouse lymphoma cells.
In the cytotoxicity Range-Finder Experiment, 6 concentrations were tested in the absence and presence of S9 mix, ranging from 24.41 to 781 µg/mL (equivalent to 10 mM at the highest concentration tested).
According to the results from the Range-Finder test, in Experiment I 10 concentrations, ranging from 50 to 781 µg/mL, were tested in the absence and presence of S9 mix.
In Experiment II 10 concentrations, ranging from 50 to 781 µg/mL in the absence of S9 mix and from 100 to 781 µg/mL in the presence of S9 mix, were tested.
Vehicle and positive control treatments were included in each Mutation Experiment.
When tested up to toxic concentrations in the absence and presence of S9 mix in Experiments I and II, there were no significant increases in mutant frequency at any concentration analysed. A weak but statistically significant linear trend was observed in the presence of S9 mix in Experiment II but, in the absence of any marked increases in mutant frequency at any test article concentration analysed in this experiment, this observation was not considered biologically relevant.
Read-across from Na2S to NaHS:
Given that sodium sulfide and sodium hydrogensulfide dissociate in aqueous media, it can safely be assumed that under most physiologically relevant conditions ( i.e., neutral pH) sulfide and hydrogen sulfide anions are present at almost equimolar concentrations, thus facilitating unrestricted read-across between both species. Only under extreme conditions such as gastric juice (pH << 2), sulfides will be present predominantly in the form of the non-dissociated hydrogen sulfide. In turn, hydrogen sulfide (H2S) may be formed from both soluble sulfides, according to the following equilibria:
Na2S + H2O → NaOH + NaHS (2Na+/ OH-/ HS-)
NaHS + H2O → NaOH + H2S (Na+/ OH-/ H2S)
Similarly, hydrogen sulfide dissociates in aqueous solution to form two dissociation states involving the hydrogen sulfide anion and the sulfide anion, according to the following equilibrium:
H2S ↔ H+ + HS- ↔ 2 H+ + S2-
In conclusion, under physiological conditions, inorganic sulfides or hydrogensulfides as well as H2S will dissociate to the respective species relevant to the pH of the physiological medium, irrespective the nature of the “sulfide”, which is why read-across between these substances and H2S is considered to be feasible without any restrictions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.